Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: Csnk1d ENSRNOG00000036676

.

Description

casein kinase 1, delta [Source:RGD Symbol;Acc:71031]

Location

Primary_assembly 10: 106,221,992-106,256,614 reverse strand.

mRatBN7.2:CM026983.1

About this gene

This gene has 4 transcripts (splice variants), 103 orthologues, 11 paralogues and is associated with 3 phenotypes.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSRNOT00000015178.8	Csnk1d-201	1784	428aa	ENSRNOP00000015178.5	Gene/transcipt that contains an open reading frame (ORF).Protein coding	Q06486-2	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSRNOT00000106442.1	Csnk1d-204	7730	402aa	ENSRNOP00000092631.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A8I6AHE0	-
ENSRNOT00000054936.4	Csnk1d-202	3445	409aa	ENSRNOP00000051819.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	Q06486-1	APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSRNOT00000099055.1	Csnk1d-203	1547	410aa	ENSRNOP00000081510.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A8I5ZSZ2	-

.

Summary

.

.